Absolute Bioavailability and Dose Proportionality of Betaxolol in Normal Healthy Subjects
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 77 (9) , 779-783
- https://doi.org/10.1002/jps.2600770913
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics of betaxolol in middle aged patientsEuropean Journal of Clinical Pharmacology, 1986
- Determination of betaxolol enantiomers by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- BetaxololDrugs, 1986
- Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.British Journal of Clinical Pharmacology, 1985
- Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in manJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta‐adrenoceptor blocking drug.British Journal of Clinical Pharmacology, 1981
- Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta‐adrenoceptor antagonist after oral and intravenous administration.British Journal of Clinical Pharmacology, 1980
- Cardiovascular effects of single oral doses of the new beta- adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers.Published by Wiley ,1980
- The NONMEM SystemThe American Statistician, 1980
- Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cycloporpylmethoxytheyl)-1-phenoxy-3-isopropyl- aminograpan-2-ol], a new β1 adrenoceptor blocking agentJournal of Chromatography A, 1979